| Literature DB >> 34746514 |
Ricvan Dana Nindrea1, Elly Usman2, Yusticia Katar2, Nissa Prima Sari3.
Abstract
INTRODUCTION: The most awaited solution is an efficient COVID-19 vaccine. COVID-19 vaccine acceptance has not been studied in a meta-analysis. The objective of this research was to find the acceptance of COVID-19 vaccination and correlated variables.Entities:
Keywords: Acceptance; COVID-19; Risk factors; Vaccine
Year: 2021 PMID: 34746514 PMCID: PMC8559452 DOI: 10.1016/j.cegh.2021.100899
Source DB: PubMed Journal: Clin Epidemiol Glob Health ISSN: 2213-3984
Fig. 1The PRISMA flowcharts.
Systematic review of COVID-19 vaccination acceptance and correlated variables among global populations.
| First author, year | Year of study | Region | Study design | Total samples | Determinant factors (OR, 95% CI) | NOS |
|---|---|---|---|---|---|---|
| Al-Qerem et al. | 2021 | Middle Eastern | Cross sectional | 1,144 | Older age (2.42, 1.22–4.79) | 7 |
| Caserotti et al. | 2021 | Italy | Cross sectional | 2,267 | Perceived risk (4.86, 3.53–6.74) | 7 |
| Ditekemena et al. | 2021 | Republic of Congo | Cross sectional | 4,131 | High income (2.31, 1.85–2.88) | 6 |
| Seale et al. | 2021 | Australia | Cross sectional | 1,420 | Female (1.40, 1.10–1.80) | 7 |
| Sallam et al. | 2021 | Jordan, Kuwait, Saudi Arabia | Cross sectional (online questionnaire) | 3,414 | Male (1.54, 1.28–1.85) | 7 |
| Qattan et al. | 2021 | Saudi Arabia | Cross sectional | 736 | Older age (2.22, 0.96–5.17) | 7 |
| Saied et al. | 2021 | Egypt | Cross sectional | 2,133 | Healthcare workers (2.26, 1.34–3.81) | 7 |
| Alley et al. | 2021 | Australia | Cross sectional | 2,343 | Female (1.89, 1.20–2.97) | 7 |
| Wong et al. | 2021 | Hongkong | A population-based survey | 1,200 | Older age (2.03, 1.48–2.77) | 7 |
| Alqudeimat et al. | 2021 | Kuwait | Cross sectional | 2,368 | Encountered with confirmed COVID-19 (5.67, 4.14–7.77) | 6 |
| Gagneux- Brunon et al. et al. | 2021 | French | Cross sectional | 1,554 | Male (2.21, 1.69–2.90) | 6 |
| Wang et al. (a) | 2021 | Hongkong | Cross sectional | 2,047 | Married (1.69, 1.33–2.14) | 7 |
| Verger et al. | 2021 | France | Cross sectional | 2,678 | Female (1.22, 0.96–1.55) | 5 |
| Nzaji et al. | 2020 | Republic of Congo | Cross sectional | 613 | Married (1.25, 0.85–1.83) | 7 |
| Lazarus et al. | 2020 | Global (19 countries) | Cross sectional | 13,426 | Older age (1.73, 1.48–2.02) | 5 |
| Detoc et al. | 2020 | France | Cross sectional (online survey) | 3,259 | Male (1.71, 1.42–2.06) | 6 |
| Bell et al. | 2020 | England | Cross sectional | 1,252 | High income (2.53, 1.67–3.83) | 6 |
| Wang et al. (b) | 2020 | Hongkong, China | Cross sectional | 806 | Male (2.78, 1.69–4.58) | 7 |
| Al-Mohaithef et al. | 2020 | Saudi Arabia | Cross sectional (web survey) | 992 | Married (1.57, 1.20–2.06) | 7 |
| Harapan et al. | 2020 | Indonesia | Cross sectional | 1,359 | Female (1.55, 1.01–2.38) | 7 |
| Lin et al. | 2020 | China | Cross sectional | 3,541 | Perceived benefits of vaccination (3.14, 2.05–4.83) | 7 |
| Malik et al. | 2020 | U·S | Cross sectional | 672 | Older age (1.81, 0.99–3.29) | 5 |
| Sherman et al. | 2020 | UK | Cross sectional | 1,500 | Older age (1.04, 0.99–1.04) | 7 |
| Wang et al. (c) | 2020 | China | Cross sectional | 2,058 | Male (1.25, 1.03–1.52) | 5 |
Abbreviation: CI = confidence interval; OR = odds ratio; NOS, Newcastle–Ottawa Quality Assessment Scale.
Meta-estimate of COVID-19 vaccination acceptance and correlated variables among global populations.
| Related factors | First author | OR (95% CI) | POR (95% CI) | Heterogeneity | |
|---|---|---|---|---|---|
| I | p | ||||
| Older Age | 1.07 (1.05–1.10) | 92.7 | <0.001 | ||
| Al-Qerem et al. | 2.42 (1.22–4.79) | ||||
| Caserotti et al. | 1.47 (1.14–1.89) | ||||
| Seale et al. | 3.10 (1.80–5.30) | ||||
| Qattan et al. | 2.22 (0.96–5.17) | ||||
| Wong et al. | 2.03 (1.48–2.77) | ||||
| Gagneux- Brunon et al. | 3.45 (1.53–7.77) | ||||
| Lazarus et al. | 1.73 (1.48–2.02) | ||||
| Detoc et al. | 2.25 (1.76–2.87) | ||||
| Harapan et al. | 2.10 (1.04–4.23) | ||||
| Malik et al. | 1.81 (0.99–3.29) | ||||
| Sherman et al. | 1.04 (0.99–1.04) | ||||
| Sallam et al. | 1.54 (1.28–1.85) | ||||
| Qattan et al. | 1.61 (0.97–2.67) | ||||
| Gagneux- Brunon et al. | 2.21 (1.69–2.90) | ||||
| Detoc et al. | 1.71 (1.42–2.06) | ||||
| Wang et al. (b) | 2.78 (1.69–4.58) | ||||
| Wang et al. (c) | 1.25 (1.03–1.52) | ||||
| Seale et al. | 1.40 (1.10–1.80) | ||||
| Alley et al. | 1.89 (1.20–2.97) | ||||
| Verger et al. | 1.22 (0.96–1.55) | ||||
| Harapan et al. | 1.55 (1.01–2.38) | ||||
| Wang et al. (a) | 1.69 (1.33–2.14) | ||||
| Nzaji et al. | 1.25 (0.85–1.83) | ||||
| Al-Mohaithef et al. | 1.57 (1.20–2.06) | ||||
| Wang et al. (c) | 1.70 (1.26–2.29) | ||||
| Ditekemena et al. | 1.82 (1.55–2.13) | ||||
| Lazarus et al. | 1.34 (1.21–1.48) | ||||
| Ditekemena et al. | 2.31 (1.85–2.88) | ||||
| Bell et al. | 2.53 (1.67–3.83) | ||||
| Saied et al. | 2.26 (1.34–3.81) | ||||
| Nzaji et al. | 1.92 (1.31–2.81) | ||||
| Detoc et al. | 1.57 (1.33–1.86) | ||||
| Harapan et al. | 1.43 (1.06–1.93) | ||||
| Ditekemena et al. | 1.26 (1.04–1.53) | ||||
| Seale et al. | 1.40 (1.10–2.000 | ||||
| Sallam et al. | 1.55 (1.15–2.09) | ||||
| Alley et al. | 1.39 (0.98–1.97) | ||||
| Wong et al. | 1.89 (1.50–2.38) | ||||
| Al-Qerem et al. | 1.50 (1.38–1.62) | ||||
| Sherman et al. | 1.08 (1.04–1.39) | ||||
| Caserotti et al. | 4.86 (3.53–6.74) | ||||
| Ditekemena et al. | 7.78 (5.75–10.53) | ||||
| Wong et al. | 1.09 (1.00–1.17) | ||||
| Gagneux- Brunon et al. | 2.09 (1.70–2.57) | ||||
| Verger et al. | 3.01 (2.38–3.79) | ||||
| Detoc et al. | 1.83 (1.54–2.16) | ||||
| Al-Mohaithef et al. | 2.48 (1.11–3.95) | ||||
| Sherman et al. | 1.03 (0.85–1.81) | ||||
| Wong et al. | 1.79 (1.59–1.99) | ||||
| Verger et al. | 1.57 (1.05–2.36) | ||||
| Lin et al. | 3.14 (2.05–4.83) | ||||
| Wang et al. (c) | 1.56 (1.08–2.25) | ||||
| Gagneux- Brunon et al. | 2.03 (1.58–2.61) | ||||
| Detoc et al. | 2.09 (1.75–2.49) | ||||
| Alqudeimat et al. | 5.67 (4.14–7.77) | ||||
| Nzaji et al. | 8.83 (1.18–66.04) | ||||
| Wang et al. (b) | 1.63 (1.14–2.33) | ||||
| Lin et al. | 1.65 (1.31–2.09) | ||||
| Alqudeimat et al. | 1.35 (1.24–1.47) | ||||
| Gagneux- Brunon et al. | 7.22 (5.68–9.19) | ||||
| Wang et al. (a) | 2.25 (1.74–2.93) | ||||
| Wang et al. (b) | 2.03 (1.47–2.81) | ||||
| Wong et al. | 1.36 (1.25–1.48) | ||||
| Lazarus et al. | 1.67 (1.54–1.80) | ||||
| Al-Mohaithef et al. | 2.85 (1.03–4.80) | ||||
Abbreviation: CI = confidence interval; OR = odds ratio; POR= Pooled odds ratio; I> 50%, heterogeneity.
Fig. 2Forest plots of COVID-19 vaccination acceptance and correlated variables among global populations.
The results of Egger's and Begg's test to assess bias among studies included.
| Related factors | Study bias | |
|---|---|---|
| Egger's test | Begg's test | |
| Older age | 0.925 | 0.139 |
| Male | 0.269 | 0.573 |
| Female | 0.137 | 0.052 |
| Married | 0.159 | 0.174 |
| High education | 0.112 | 0.317 |
| Low income | 0.115 | 0.317 |
| Healthcare workers | 0.304 | 0.174 |
| Chronic diseases | 0.804 | 1.000 |
| High level of knowledge | 0.811 | 0.317 |
| Perceived risk | 0.577 | 0.458 |
| Perceived benefits | 0.740 | 0.497 |
| Fear about COVID-19 | 0.160 | 0.227 |
| Encountered with COVID-19 | 0.051 | 0.174 |
| Flu vaccine during the previous season | 0.280 | 1.000 |
| Trust in health system | 0.767 | 0.602 |
p > 0.05, no publication bias.
Fig. 3The association between LMICs and COVID-19 vaccine acceptance based on meta-regression.